Capitalizing on Opportunities in
Cord Blood Industry Growth
BioInformant Worldwide, L.L.C.
Market Report
Format: PDF; 196 Pages
* Launched January 2010 *
 Overview: Over the past 12 months, the cord blood banking industry has expanded through double digit growth, due to new entrants in the cord blood banking industry as well as revenue growth at existing operations. Deeper analysis reveals that of existing cord blood banks, most fall into one of two “camps,” either experiencing flat-line growth (less than 3% per annum) or substantively building revenue (17% or more per annum).
This finding begs the questions: - What factors are causing a substantial number of new cord blood banks to open up business? Is it the result of a profit opportunity, an effect of advances in therapeutic applications, a social response to more parents being aware of the opportunity to store cord stem cells at birth, or are other factors driving the activity?
- What will be the effect of these new entrants to the cord blood banking industry for existing competitors?
- Perhaps most critically, what are the differences among the cord blood banks that are experiencing flat-line growth, versus those that have substantively built revenue over the past 12 months?
In BioInformant’s initial version of this report, "Choices in Cord Blood Banking – Factors Influencing Parental Decision-Making," launched April 2009, an survey of 1,200 expectant parents was used to provide a roadmap for how cord blood banks can best communicate and market their services to potential clients. The top-selling report explored the specific reasons that parents elect to store cord blood and what factors influence their decision-making in choosing a specific bank. (Click here to read the Executive Summary for the original version of the report.) This expanded and updated version includes all content from the original report, as well as supplemental analysis of factors that have produced double-digit industry growth over the past year. It provides guidance on how to break through flat-line growth to become a fast-growing competitor within the cord blood industry. Because we believe all customers should be repeat customers, BioInformant market reports are backed by a progressive 60 Day Guarantee.
TABLE OF CONTENTS: Capitalizing on Opportunities in Cord Blood Industry Growth
Pricing: List Price: USD $3,495 (Approximately €2,395))
* All major international currencies accepted. Report delivered by email in PDF format.
* Report Content may be Purchased by Section: A "Slice and Price" model is used to calculate cost, in which the desired number of pages is taken as a fraction of the reports total pages and a 10% premium is added. To inquire about "Price and Slice", Small Business (20 employees or less) price reductions or other needs pertaining to purchase of this market report, inquire at info@bioinformant.com or by phone at 703-859-7617.
(Phone) 703-859-7617 info@bioinformant.com (Fax) 614-352-2369
Copyright © 2010 BioInformant Worldwide, L.L.C. All rights reserved.
|
